62
Views
11
CrossRef citations to date
0
Altmetric
Review

Assessment, pathophysiology and treatment of fatigue in multiple sclerosis

&
Pages 867-876 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Thomas Müller, Peter Riederer & Wilfried Kuhn. (2023) Aminoadamantanes: from treatment of Parkinson’s and Alzheimer’s disease to symptom amelioration of long COVID-19 syndrome?. Expert Review of Clinical Pharmacology 16:2, pages 101-107.
Read now
Thomas Müller. (2018) Safinamide: an add-on treatment for managing Parkinson’s disease. Clinical Pharmacology: Advances and Applications 10, pages 31-41.
Read now
Thomas Müller. (2017) Pharmacokinetic drug evaluation of safinamide mesylate for the treatment of mid-to-late stage Parkinson’s disease. Expert Opinion on Drug Metabolism & Toxicology 13:6, pages 693-699.
Read now

Articles from other publishers (8)

Yeon Hak Chung, Ansuk Jeong, Byoung Joon Kim, Kwangbai Park & Ju-Hong Min. (2022) Validity and reliability of Korean version of Modified Fatigue Impact Scale (MFIS) for Korean patients with multiple sclerosis. Multiple Sclerosis and Related Disorders 62, pages 103811.
Crossref
Fioravante Capone, Sara Collorone, Rosa Cortese, Vincenzo Di Lazzaro & Marcello Moccia. (2019) Fatigue in multiple sclerosis: The role of thalamus. Multiple Sclerosis Journal 26:1, pages 6-16.
Crossref
Anna L. Kratz, Kevin N. Alschuler, Dawn M. Ehde, Gloria von Geldern, Roderick Little, Shubhangi Kulkarni, Kristen Pickup & Tiffany J. Braley. (2019) A randomized pragmatic trial of telephone-delivered cognitive behavioral-therapy, modafinil, and combination therapy of both for fatigue in multiple sclerosis: The design of the “COMBO-MS” trial. Contemporary Clinical Trials 84, pages 105821.
Crossref
Harry J. Pick, Charlotte E. Bolton, Wei Shen Lim & Tricia M. McKeever. (2019) Patient-reported outcome measures in the recovery of adults hospitalised with community-acquired pneumonia: a systematic review. European Respiratory Journal 53:3, pages 1802165.
Crossref
Thomas Müller & Paul Foley. (2016) Clinical Pharmacokinetics and Pharmacodynamics of Safinamide. Clinical Pharmacokinetics 56:3, pages 251-261.
Crossref
Martin Langeskov-Christensen, Etienne J. Bisson, Marcia L. Finlayson & Ulrik Dalgas. (2017) Potential pathophysiological pathways that can explain the positive effects of exercise on fatigue in multiple sclerosis: A scoping review. Journal of the Neurological Sciences 373, pages 307-320.
Crossref
Kenneth R. DillerLiang Zhu. (2009) Hypothermia Therapy for Brain Injury. Annual Review of Biomedical Engineering 11:1, pages 135-162.
Crossref
Letizia Leocani, Bruno Colombo & Giancarlo Comi. (2008) Physiopathology of fatigue in Multiple Sclerosis. Neurological Sciences 29:S2, pages 241-243.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.